ECMO timing study for children with hard-to-treat septic shock
Part of Infections clinical trials.
This trial looks at whether and when a heart-lung machine called ECMO should be used in children whose septic shock is not responding to standard treatment. It may help doctors choose the best timing to improve survival and recovery in the PICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is in the pediatric ICU (PICU) for septic shock
- Your child’s septic shock is not improving despite treatment (refractory septic shock)
- Your child does not have a fatal chromosome condition (for example, trisomy 13 or 18)
- Your child does not have bleeding that cannot be controlled
- Your child does not have irreversible brain damage
- Your child has not had an allogeneic bone marrow transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at using a specific heart-lung support machine (the EUROSETS ECMOLIFE system) for adults who need urgent “extra” circulation support. It may help clinicians understand how well the device works in serious situations like shock, cardiac arrest, or after heart surgery.
This trial is for people with severe lung failure (ARDS) who are already on a life-support machine called VV-ECMO. It tests whether adding a special breathing tube (CPAP) can help their lungs heal better.
This trial looks at how well the heart and blood vessels are working in people with septic shock. It helps doctors decide the best way to reduce blood pressure medication safely.
This study tests a new way to give fluids during sepsis in children to improve blood flow and recovery. It compares a standard saltwater solution to a plasma-based solution to see which works better.
This study tests whether therapeutic plasma exchange (a procedure that removes and replaces blood plasma) can improve outcomes in ICU patients with septic shock that is not responding to standard medicines. It may help some people whose infection-related illness is causing failing organs.
This study looks at children (ages 1 day to 18 years) in mainland China who were treated with ECMO during the past 10 years. It aims to understand how ECMO was used and how care outcomes may have differed for children.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.